Back to search
FDAFDA · Food and drugs·Recall number D-0076-2018

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL. 10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7

Published November 22, 2017 · Recall initiated: August 31, 2017

Summary

FDA records drug Class II recall D-0076-2018, published November 22, 2017 and initiated August 31, 2017. Recalling firm: Amneal Pharmaceuticals LLC; Status: Terminated; Reported quantity: 14,000 vials; Lot: Lot # AP160016; Exp. 05/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amneal Pharmaceuticals LLC
Distributor
MS, NC, OH, TX, UT
Lot
Lot # AP160016; Exp. 05/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL. 10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7 recalled?

Yes. FDA published recall D-0076-2018 on November 22, 2017. Reported hazard: Presence of Particulate Matter

What should I do if I have this product?

Voluntary: Firm initiated · Letter